KMID : 0311120070480020225
|
|
Yonsei Medical Journal 2007 Volume.48 No. 2 p.225 ~ p.232
|
|
Polypoidal Choroidal Vasculopathy in Korean Patients with Large Submacular Hemorrhage
|
|
Yoon Jin-Sook
Lee Jong-Hyun Lee Sung-Chul Koh Hyoung-Jun Kim Sung-Soo Kwon Oh-Woong
|
|
Abstract
|
|
|
Purpose: To determine and compare the clinical characteristics, visual prognosis and treatment of hemorrhagic polypoidal choroidal vasculopathy (HPCV) with those of hemorrhagic choroidal neovascularization (HCNV) due to age-related macular degeneration (ARMD).
Materials & Methods: Retrospective analysis of 44 consecutive eyes with a submacular hemorrhage comprising more than 50% of the neovascular lesion. Patients were diagnosed as having HPCV or HCNV on the basis of indocyanine green angiography.
Results: Of the 44 eyes with submacular hemorrhage, 26 were classified as HPCV and 18 as HCNV. The baseline patient characteristics were similar for both groups. At the final follow-up the HPCV group had 17 eyes showing visual improvement, four showing maintained vision, and five showing visual deterioration. In contrast, the HCNV group had four eyes showing visual improvement, one showing maintained vision, and 13 showing visual deterioration. Visual acuity of < 0.1 at follow-up was found in 7 (27%) of HPCV eyes and 10 (56%) of HCNV eyes. PDT was performed in 15 HPCV eyes, of which 13 (87%) showed improvement or no change in visual acuity, while only 2 (22%) of the 9 HCNV eyes responded similarly after PDT. Eyes treated with PDT did not have better outcomes compared to eyes that underwent other types of treatment (Fisher¡¯s exact test, p > 0.05).
Conclusion: PCV accounts for the largest proportion of submacular hemorrhage in Koreans. PCV showed a better visual prognosis than CNV.
|
|
KEYWORD
|
|
Submacular hemorrhage, hemorrhagic polypoidal choroidal vasculopathy, hemorrhagic choroidal neovascularization, photodynamic therapy
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|